A Connexin-Based Biomarker Model Applicable for Prognosis and Immune Landscape Assessment in Lung Adenocarcinoma

Figure 3

Development of a prognostic model. (a) Univariate Cox regression analysis. (b) Multivariate regression analysis for model construction. (c) Expression level of six model genes (LOXL2, PTPRH, DKK1, PKP2, NKX2-1, and KRT6A) from the GEPIA database.

(a)

(b)

(c)